SCHEMBL7125975

SCHEMBL7125975

Cc1ccc(C(=O)Nc2nc3ccc(NC(=O)c4cc([N+](=O)[O-])ccc4Cl)cc3s2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.62
MMP13 P45452 2/20 0.62
PPARG P37231 4/20 0.61
HTT P42858 3/20 0.60
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
ALDH1A1 P00352 3/20 0.58
RAB9A P51151 5/20 0.58
MCL1 Q07820 2/20 0.58
HPGD P15428 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
NPC1 O15118 3/20 0.58
SCD O00767 2/20 0.57
DYRK1A Q13627 1/20 0.55
CACNA1B Q00975 1/20 0.54
APBA1 Q02410 1/20 0.54
LMNA P02545 3/20 0.52
RECQL P46063 2/20 0.52
MAPK1 P28482 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7123602 0.89 DYRK1A (0.67) MAPTMMP13HTTMEN1KMT2A
SCHEMBL7162058 0.89 DYRK1A (0.64) MAPTMMP13PPARGHTTMEN1
SCHEMBL7125923 0.86 DYRK1A (0.57) MAPTMMP13PPARGHTTMEN1
SCHEMBL7128296 0.86 NPC1 (0.77) MAPTMMP13MEN1KMT2AALDH1A1
SCHEMBL7129461 0.86 DYRK1A (0.70) MAPTMMP13PPARGHTTMEN1
SCHEMBL7119682 0.83 KMT2A (0.69) MAPTPPARGHTTMEN1KMT2A
SCHEMBL7124202 0.83 DYRK1A (0.54) MAPTMMP13PPARGHTTMEN1
SCHEMBL7127487 0.83 MMP13 (0.74) MAPTMMP13HTTMEN1KMT2A
SCHEMBL7124297 0.82 DYRK1A (0.61) MAPTMMP13PPARGHTTMEN1
SCHEMBL7119606 0.81 MAPT (0.61) MAPTMMP13HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD MAPT 4391/4885MMP13 2283/4885PPARG 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.